Employees: 11 (2023.0)Legal category: SCA (commandite par actions)Size: PMECreation date: 2004-01-19 (22 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: LYON (69002), Rhone
PHARMACIE DE LA SCALA : revenue, balance sheet and financial ratios
PHARMACIE DE LA SCALA is a French company
founded 22 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in LYON (69002),
this company of category PME
shows in 2020 a revenue of 2.4 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE LA SCALA (SIREN 452388440)
Indicator
2024
2023
2020
2019
2018
Revenue
N/C
N/C
2 403 090 €
2 496 573 €
2 411 690 €
Net income
402 €
-61 080 €
96 294 €
49 005 €
47 337 €
EBITDA
N/C
N/C
149 459 €
144 242 €
106 664 €
Net margin
N/C
N/C
4.0%
2.0%
2.0%
Revenue and income statement
In 2024, PHARMACIE DE LA SCALA generates positive net income of 402 €. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2024: 47 k€ -> 402 €.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
402 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 511%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 12%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
510.53%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
12.318%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE LA SCALA
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2023
2024
Debt ratio
-3609.474
-85382.78
2123.846
563.005
510.53
Financial autonomy
-2.44
-0.1
3.884
11.831
12.318
Repayment capacity
19.801
15.38
18.536
None
None
Cash flow / Revenue
3.837%
4.726%
4.454%
None%
None%
Sector positioning
Debt ratio
510.532024
2020
2023
2024
Q1: 16.45
Med: 58.41
Q3: 154.59
Average
In 2024, the debt ratio of PHARMACIE DE LA SCALA (510.53) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
12.32%2024
2020
2023
2024
Q1: 28.92%
Med: 49.95%
Q3: 69.49%
Watch
In 2024, the financial autonomy of PHARMACIE DE LA SCALA (12.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Repayment capacity
18.54 years2020
2020
Q1: 1.45 years
Med: 4.71 years
Q3: 9.29 years
Average
In 2020, the repayment capacity of PHARMACIE DE LA SCALA (18.54) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 156.66. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
156.659
Liquidity indicators evolution PHARMACIE DE LA SCALA
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2023
2024
Liquidity ratio
170.596
175.392
257.314
169.582
156.659
Interest coverage
19.19
28.943
6.721
None
None
Sector positioning
Liquidity ratio
156.662024
2020
2023
2024
Q1: 129.47
Med: 182.14
Q3: 260.79
Average-37 pts over 3 years
In 2024, the liquidity ratio of PHARMACIE DE LA SCALA (156.66) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Interest coverage
6.72x2020
2020
Q1: 0.68x
Med: 3.88x
Q3: 8.36x
Good
In 2020, the interest coverage of PHARMACIE DE LA SCALA (6.7x) ranks above the median of the sector. This ratio indicates how many times operating income covers interest expenses. This comfortable position offers an appreciable safety margin.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE DE LA SCALA
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2023
2024
Operating WCR
462 634 €
460 143 €
572 128 €
0 €
0 €
Inventory turnover (days)
66
67
85
0
0
Customer payment term (days)
4
2
6
0
0
Supplier payment term (days)
48
49
46
0
0
Positioning of PHARMACIE DE LA SCALA in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE DE LA SCALA is estimated at
5 612 €
(range 3 908€ - 8 396€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
3k€5k€8k€
5 612 €Range: 3 908€ - 8 396€
NAF 5 année 2024
Valuation method used
Net Income Multiple
402 €
×
14.0x
=5 612 €
Range: 3 908€ - 8 396€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE LA SCALA with other companies in the same sector:
Frequently asked questions about PHARMACIE DE LA SCALA
What is the revenue of PHARMACIE DE LA SCALA ?
The revenue of PHARMACIE DE LA SCALA in 2020 is 2.4 M€.
Is PHARMACIE DE LA SCALA profitable?
Yes, PHARMACIE DE LA SCALA generated a net profit of 402€ in 2024.
Where is the headquarters of PHARMACIE DE LA SCALA ?
The headquarters of PHARMACIE DE LA SCALA is located in LYON (69002), in the department Rhone.
Where to find the tax return of PHARMACIE DE LA SCALA ?
The tax return of PHARMACIE DE LA SCALA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE LA SCALA operate?
PHARMACIE DE LA SCALA operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart